Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies

被引:0
作者
Ying Li
Alice Saul
Bruce Taylor
Anne-Louise Ponsonby
Steve Simpson-Yap
Leigh Blizzard
Simon Broadley
Jeannette Lechner-Scott
Rana Karabudak
Francesco Patti
Sara Eichau
Marco Onofrj
Serkan Ozakbas
Dana Horakova
Eva Kubala Havrdova
Francois Grand’Maison
Raed Alroughani
Oliver Gerlach
Maria Pia Amato
Ayse Altintas
Marc Girard
Pierre Duquette
Yolanda Blanco
Cristina Ramo-Tello
Guy Laureys
Tomas Kalincik
Samia J. Khoury
Vahid Shaygannejad
Masoud Etemadifar
Bhim Singhal
Saloua Mrabet
Matteo Foschi
Mario Habek
Nevin John
Stella Hughes
Pamela McCombe
Radek Ampapa
Anneke van der Walt
Helmut Butzkueven
Koen de Gans
Chris McGuigan
Celia Oreja-Guevara
Maria Jose Sa
Thor Petersen
Talal Al-Harbi
Angel Perez Sempere
Bart Van Wijmeersch
Nikolaos Grigoriadis
Julie Prevost
Orla Gray
机构
[1] University of Tasmania,Menzies Institute of Medical Research
[2] University of Melbourne,Florey Institute for Neuroscience
[3] Neuroepidemiology Unit,Melbourne School of Population and Global Health
[4] The University of Melbourne,School of Medicine and Dentistry
[5] Griffith University,Hunter Medical Research Institute
[6] University of Newcastle,Department of Medical and Surgical Sciences and Advanced Technologies
[7] Hacettepe University,UOS Sclerosi Multipla, AOU Policlinico “G Rodloico
[8] GF Ingrassia,San Marco”
[9] University of Catania,School for Mental Health and Neuroscience
[10] Hospital Universitario Virgen Macarena,Department of Neurology and Koc University Research Center for Translational Medicine (KUTTAM)
[11] University G. d’Annunzio,Department of Neurology
[12] Dokuz Eylul University,Department of Medicine
[13] Charles University in Prague and General University Hospital,Department of Neurology, LR 18SP03, Clinical Investigation Centre Neurosciences and Mental Health
[14] Neuro Rive-Sud,Faculty of Medicine of Tunis
[15] Amiri Hospital,Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology
[16] Zuyderland Medical Center,Department of Medicine
[17] Maastricht University,Central Clinical School
[18] University of Florence,Faculty of Health Sciences
[19] Koc University,Department of Medicine
[20] School of Medicine,Florey Institute for Neuroscience
[21] CHUM and Universite de Montreal,Dipartimento di Scienze Biomediche e Neuromotorie
[22] Hospital Clinic de Barcelona,undefined
[23] Hospital Germans Trias i Pujol,undefined
[24] Universitary Hospital Ghent,undefined
[25] Neroimmunology Centre,undefined
[26] Royal Melbourne Hospital,undefined
[27] CORe,undefined
[28] University of Melbourne,undefined
[29] American University of Beirut Medical Center,undefined
[30] Isfahan University of Medical Sciences,undefined
[31] Al Zahra Hospital,undefined
[32] Bombay Hospital Institute of Medical Sciences,undefined
[33] University Hospital Razi-Manouba,undefined
[34] University of Tunis El Manar,undefined
[35] S. Maria delle Croci Hospital,undefined
[36] AUSL Romagna,undefined
[37] University of L’Aquila,undefined
[38] University Hospital Center Zagreb,undefined
[39] University of Zagreb,undefined
[40] School of Medicine,undefined
[41] Monash Medical Centre,undefined
[42] School of Clinical Sciences,undefined
[43] Monash University,undefined
[44] Royal Victoria Hospital,undefined
[45] Royal Brisbane and Women’s Hospital,undefined
[46] University of Queensland,undefined
[47] Nemocnice Jihlava,undefined
[48] The Alfred Hospital,undefined
[49] Monash University,undefined
[50] Monash University,undefined
来源
Journal of Neurology | 2024年 / 271卷
关键词
Progressive-onset multiple sclerosis; Environmental factors; Case–control; Subject recruitment; Bias;
D O I
暂无
中图分类号
学科分类号
摘要
It is unknown whether the currently known risk factors of multiple sclerosis reflect the etiology of progressive-onset multiple sclerosis (POMS) as observational studies rarely included analysis by type of onset. We designed a case–control study to examine associations between environmental factors and POMS and compared effect sizes to relapse-onset MS (ROMS), which will offer insights into the etiology of POMS and potentially contribute to prevention and intervention practice. This study utilizes data from the Primary Progressive Multiple Sclerosis (PPMS) Study and the Australian Multi-center Study of Environment and Immune Function (the AusImmune Study). This report outlines the conduct of the PPMS Study, whether the POMS sample is representative, and the planned analysis methods. The study includes 155 POMS, 204 ROMS, and 558 controls. The distributions of the POMS were largely similar to Australian POMS patients in the MSBase Study, with 54.8% female, 85.8% POMS born before 1970, mean age of onset of 41.44 ± 8.38 years old, and 67.1% living between 28.9 and 39.4° S. The POMS were representative of the Australian POMS population. There are some differences between POMS and ROMS/controls (mean age at interview: POMS 55 years vs. controls 40 years; sex: POMS 53% female vs. controls 78% female; location of residence: 14.3% of POMS at a latitude ≤ 28.9°S vs. 32.8% in controls), which will be taken into account in the analysis. We discuss the methodological issues considered in the study design, including prevalence-incidence bias, cohort effects, interview bias and recall bias, and present strategies to account for it. Associations between exposures of interest and POMS/ROMS will be presented in subsequent publications.
引用
收藏
页码:472 / 485
页数:13
相关论文
共 368 条
[1]  
Campbell JA(2019)Change in multiple sclerosis prevalence over time in Australia 2010–2017 utilising disease-modifying therapy prescription data Mult Scler 83 278-286
[2]  
Simpson S(2014)Defining the clinical course of multiple sclerosis: the 2013 revisions Neurology 123 627-638
[3]  
Ahmad H(2012)Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? Acta Neuropathol 19 266-267
[4]  
Taylor BV(2013)Relapsing–remitting and primary progressive MS have the same cause (s)–the neuropathologist’s view: 1 Mult Scler J 136 3609-3617
[5]  
van der Mei I(2013)Sex as a determinant of relapse incidence and progressive course of multiple sclerosis Brain 87 1343-1349
[6]  
Palmer AJ(2016)Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis J Neurol Neurosur Ps 16 398-405
[7]  
Lublin FD(2010)Latitudinal variation in incidence and type of first central nervous system demyelinating events Mult Scler 16 1422-1431
[8]  
Reingold SC(2010)MS prevalence in New Zealand, an ethnically and latitudinally diverse country Mult Scler 6 903-912
[9]  
Cohen JA(2007)Primary-progressive multiple sclerosis Lancet Neurol 2015 461-469
[10]  
Cutter GR(2015)Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review BioMed Res Int 22 209-220